
We are building a full stack salivary prognostics company to accelerate and lower the cost of non-invasive prognostics. We are based in Europe.

We are building a full stack salivary prognostics company to accelerate and lower the cost of non-invasive prognostics. We are based in Europe.
What they do: Saliva-based biomarker testing platform for athlete performance and recovery
Location: Tulln an der Donau, Niederösterreich, Austria
Founded: June 8, 2021
Team size: Around 17 employees
Analysis speed & scale: 24–48 hour turnaround for 100–125+ biomarkers
Recent funding: Seed round (Aug 2024); prior angel and grant support
Sports performance, recovery, and injury-risk monitoring via biomarker analytics
2021
Bioanalytics / Healthtech / Sports performance
Seed round reported Aug 2024
Seven-figure (reported)
Reported angel investment and an Austrian Life Science grant
| Company |
|---|
About Biolyz
Biolyz is a saliva-based biomarker testing solution. We provide daily saliva testing with a 24h analysis timeline for over 125+ biomarkers. We leverage biomarkers to predict injuries and performance for athlete teams.
Based in Austria, we collaborate with top football clubs and high-level sports organizations, offering a fast-paced, innovative environment where your expertise can have a real impact.
Your Responsibilities
Your Profile
What We Offer
We look forward to your application. We typically have 3 rounds of interviews: 1) Async Screening Interview; 2) Technical discussion and assessment; 3) Management Review for final decision.